AAPL333.69+3.37 (+1.02%) ▲|ABBV262.82+2.89 (+1.11%) ▲|ABT97.50+0.81 (+0.84%) ▲|ACN198.90-13.40 (-6.31%) ▼|ADBE237.69-3.59 (-1.49%) ▼|AMAT540.04+10.74 (+2.03%) ▲|AMD633.91+18.18 (+2.95%) ▲|AMGN403.04-4.23 (-1.04%) ▼|AMT162.20+1.14 (+0.71%) ▲|AMZN251.52+3.29 (+1.33%) ▲|AVGO355.14+11.50 (+3.35%) ▲|AXP302.78+0.69 (+0.23%) ▲|BA193.56+1.28 (+0.67%) ▲|BAC53.75+0.02 (+0.04%) ▲|BKNG159.02-1.26 (-0.79%) ▼|BLK1,059.63-4.73 (-0.44%) ▼|BMY61.15+0.32 (+0.53%) ▲|BNY145.40+1.48 (+1.03%) ▲|BRK-B502.65+2.15 (+0.43%) ▲|C128.50+1.50 (+1.18%) ▲|CAT845.42+19.07 (+2.31%) ▲|CL84.26-0.27 (-0.32%) ▼|CMCSA21.57-0.13 (-0.60%) ▼|COF194.72+0.24 (+0.12%) ▲|COP126.75-0.31 (-0.24%) ▼|COST920.65+5.71 (+0.62%) ▲|CRM234.69-2.00 (-0.85%) ▼|CSCO112.20+3.86 (+3.56%) ▲|CVS86.46+1.26 (+1.48%) ▲|CVX206.69-0.41 (-0.20%) ▼|DE687.00+19.74 (+2.96%) ▲|DHR214.06+2.30 (+1.09%) ▲|DIS102.19+0.86 (+0.85%) ▲|DUK114.13+0.39 (+0.34%) ▲|EMR161.61+3.04 (+1.92%) ▲|FDX290.36+3.29 (+1.15%) ▲|GD330.09-2.63 (-0.79%) ▼|GE309.56-2.83 (-0.91%) ▼|GEV988.70+1.25 (+0.13%) ▲|GILD144.74-2.76 (-1.87%) ▼|GM78.27-1.04 (-1.31%) ▼|GOOG340.35+5.42 (+1.62%) ▲|GOOGL343.50+5.26 (+1.56%) ▲|GS902.56+5.89 (+0.66%) ▲|HD282.85+0.39 (+0.14%) ▲|HON213.99+0.19 (+0.09%) ▲|IBM222.64-2.98 (-1.32%) ▼|INTC119.33-0.67 (-0.56%) ▼|INTU281.08-1.70 (-0.60%) ▼|ISRG391.95-9.29 (-2.32%) ▼|JNJ256.03-2.63 (-1.02%) ▼|JPM332.38-0.80 (-0.24%) ▼|KO85.65-0.45 (-0.52%) ▼|LIN479.48+10.03 (+2.14%) ▲|LLY1,142.85-7.00 (-0.61%) ▼|LMT505.41-0.09 (-0.02%) ▼|LOW180.80-1.58 (-0.87%) ▼|LRCX347.49+7.39 (+2.17%) ▲|MA552.26+2.26 (+0.41%) ▲|MCD231.89+0.06 (+0.03%) ▲|MDLZ58.19+0.43 (+0.74%) ▲|MDT86.38-0.06 (-0.07%) ▼|META728.08+2.15 (+0.30%) ▲|MMM161.89-1.13 (-0.69%) ▼|MO67.35+0.40 (+0.60%) ▲|MRK144.30+0.49 (+0.34%) ▲|MS190.31+2.30 (+1.22%) ▲|MSFT517.53+4.73 (+0.92%) ▲|MU1,074.89-22.50 (-2.05%) ▼|NEE76.83+0.48 (+0.63%) ▲|NFLX67.06-0.79 (-1.16%) ▼|NKE33.87-1.28 (-3.64%) ▼|NOW134.38-3.38 (-2.45%) ▼|NVDA233.95+3.09 (+1.34%) ▲|ORCL142.30+4.23 (+3.06%) ▲|PEP125.89+0.29 (+0.23%) ▲|PFE27.80-0.32 (-1.14%) ▼|PG144.91+0.96 (+0.67%) ▲|PLTR188.75-1.29 (-0.68%) ▼|PM187.46+0.88 (+0.47%) ▲|QCOM184.87+2.78 (+1.53%) ▲|RTX184.68-0.33 (-0.18%) ▼|SBUX94.71-0.17 (-0.18%) ▼|SCHW96.70-1.67 (-1.70%) ▼|SO83.72+0.25 (+0.30%) ▲|SPG200.95+0.14 (+0.07%) ▲|T24.30+0.00 (+0.00%) ▲|TMO654.80+2.29 (+0.35%) ▲|TMUS163.64+1.91 (+1.18%) ▲|TSLA370.59+16.48 (+4.65%) ▲|TXN293.80+12.49 (+4.44%) ▲|UBER68.11+0.23 (+0.34%) ▲|UNH371.90+6.70 (+1.83%) ▲|UNP278.28+5.86 (+2.15%) ▲|UPS93.02-0.87 (-0.93%) ▼|USB57.51+0.15 (+0.26%) ▲|V360.66+0.81 (+0.23%) ▲|VZ45.92-0.06 (-0.13%) ▼|WFC80.45+0.20 (+0.25%) ▲|WMT104.26+0.00 (+0.00%) ▲|XOM164.01+0.19 (+0.12%) ▲|AAPL333.69+3.37 (+1.02%) ▲|ABBV262.82+2.89 (+1.11%) ▲|ABT97.50+0.81 (+0.84%) ▲|ACN198.90-13.40 (-6.31%) ▼|ADBE237.69-3.59 (-1.49%) ▼|AMAT540.04+10.74 (+2.03%) ▲|AMD633.91+18.18 (+2.95%) ▲|AMGN403.04-4.23 (-1.04%) ▼|AMT162.20+1.14 (+0.71%) ▲|AMZN251.52+3.29 (+1.33%) ▲|AVGO355.14+11.50 (+3.35%) ▲|AXP302.78+0.69 (+0.23%) ▲|BA193.56+1.28 (+0.67%) ▲|BAC53.75+0.02 (+0.04%) ▲|BKNG159.02-1.26 (-0.79%) ▼|BLK1,059.63-4.73 (-0.44%) ▼|BMY61.15+0.32 (+0.53%) ▲|BNY145.40+1.48 (+1.03%) ▲|BRK-B502.65+2.15 (+0.43%) ▲|C128.50+1.50 (+1.18%) ▲|CAT845.42+19.07 (+2.31%) ▲|CL84.26-0.27 (-0.32%) ▼|CMCSA21.57-0.13 (-0.60%) ▼|COF194.72+0.24 (+0.12%) ▲|COP126.75-0.31 (-0.24%) ▼|COST920.65+5.71 (+0.62%) ▲|CRM234.69-2.00 (-0.85%) ▼|CSCO112.20+3.86 (+3.56%) ▲|CVS86.46+1.26 (+1.48%) ▲|CVX206.69-0.41 (-0.20%) ▼|DE687.00+19.74 (+2.96%) ▲|DHR214.06+2.30 (+1.09%) ▲|DIS102.19+0.86 (+0.85%) ▲|DUK114.13+0.39 (+0.34%) ▲|EMR161.61+3.04 (+1.92%) ▲|FDX290.36+3.29 (+1.15%) ▲|GD330.09-2.63 (-0.79%) ▼|GE309.56-2.83 (-0.91%) ▼|GEV988.70+1.25 (+0.13%) ▲|GILD144.74-2.76 (-1.87%) ▼|GM78.27-1.04 (-1.31%) ▼|GOOG340.35+5.42 (+1.62%) ▲|GOOGL343.50+5.26 (+1.56%) ▲|GS902.56+5.89 (+0.66%) ▲|HD282.85+0.39 (+0.14%) ▲|HON213.99+0.19 (+0.09%) ▲|IBM222.64-2.98 (-1.32%) ▼|INTC119.33-0.67 (-0.56%) ▼|INTU281.08-1.70 (-0.60%) ▼|ISRG391.95-9.29 (-2.32%) ▼|JNJ256.03-2.63 (-1.02%) ▼|JPM332.38-0.80 (-0.24%) ▼|KO85.65-0.45 (-0.52%) ▼|LIN479.48+10.03 (+2.14%) ▲|LLY1,142.85-7.00 (-0.61%) ▼|LMT505.41-0.09 (-0.02%) ▼|LOW180.80-1.58 (-0.87%) ▼|LRCX347.49+7.39 (+2.17%) ▲|MA552.26+2.26 (+0.41%) ▲|MCD231.89+0.06 (+0.03%) ▲|MDLZ58.19+0.43 (+0.74%) ▲|MDT86.38-0.06 (-0.07%) ▼|META728.08+2.15 (+0.30%) ▲|MMM161.89-1.13 (-0.69%) ▼|MO67.35+0.40 (+0.60%) ▲|MRK144.30+0.49 (+0.34%) ▲|MS190.31+2.30 (+1.22%) ▲|MSFT517.53+4.73 (+0.92%) ▲|MU1,074.89-22.50 (-2.05%) ▼|NEE76.83+0.48 (+0.63%) ▲|NFLX67.06-0.79 (-1.16%) ▼|NKE33.87-1.28 (-3.64%) ▼|NOW134.38-3.38 (-2.45%) ▼|NVDA233.95+3.09 (+1.34%) ▲|ORCL142.30+4.23 (+3.06%) ▲|PEP125.89+0.29 (+0.23%) ▲|PFE27.80-0.32 (-1.14%) ▼|PG144.91+0.96 (+0.67%) ▲|PLTR188.75-1.29 (-0.68%) ▼|PM187.46+0.88 (+0.47%) ▲|QCOM184.87+2.78 (+1.53%) ▲|RTX184.68-0.33 (-0.18%) ▼|SBUX94.71-0.17 (-0.18%) ▼|SCHW96.70-1.67 (-1.70%) ▼|SO83.72+0.25 (+0.30%) ▲|SPG200.95+0.14 (+0.07%) ▲|T24.30+0.00 (+0.00%) ▲|TMO654.80+2.29 (+0.35%) ▲|TMUS163.64+1.91 (+1.18%) ▲|TSLA370.59+16.48 (+4.65%) ▲|TXN293.80+12.49 (+4.44%) ▲|UBER68.11+0.23 (+0.34%) ▲|UNH371.90+6.70 (+1.83%) ▲|UNP278.28+5.86 (+2.15%) ▲|UPS93.02-0.87 (-0.93%) ▼|USB57.51+0.15 (+0.26%) ▲|V360.66+0.81 (+0.23%) ▲|VZ45.92-0.06 (-0.13%) ▼|WFC80.45+0.20 (+0.25%) ▲|WMT104.26+0.00 (+0.00%) ▲|XOM164.01+0.19 (+0.12%) ▲|

17 C

New York

Sunday, October 4, 2026

SMPL DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages The Simply Good Foods Company Investors to Secure Counsel Before Important October 13 Deadline...

AZP Insurance Specialists Certifies Gateless Smart Underwrite® Under New AI and Insurance-Backed Risk Framework

Canada and Alberta to collaborate on High-Speed Rail

globenewswire

Author's Latest

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 72,000 restricted stock units of Arcutis’ common stock to nine newly hired employees. These awards were approved by the Compensation Committee of Arcutis’ Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of June 2, 2025, as an inducement material to the new employees entering into employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4).

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Company announcement – No. 14 / 2025

Camwood Capital Group Names Co-Founder Matt Mayfield as President and CEO in Strategic Leadership Move

Camwood Capital Group (“Camwood”), a private investment firm focused on long-term value creation in industrial sectors and specializing in lower middle-market companies, has officially named co-founder Matt Mayfield as its new Chief Executive Officer and President of TCMG.

Camwood Capital Group (“Camwood”), a private investment firm focused on long-term value creation in industrial sectors and specializing in lower middle-market companies, has officially named co-founder Matt Mayfield as its new Chief Executive Officer and President of TCMG.

XOVR ETF Adds Anduril, Joining SpaceX to Offer Pre-IPO Access

XOVR ETF Adds Anduril to Crossover Fund. Joins SpaceX and Klarna as Private Equity Holdings in ETF that Holds 85%+ of Entrepreneur 30 Total Return Index

Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.

Collaboration entre OBI Pharma et TegMine Therapeutics autour des ADC, reposant sur les technologies habilitantes GlycOBI® et TegMiner™

TAIPEI, Taïwan, 06 juin 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), une société internationale d’oncologie au stade clinique, spécialisée dans le développement de nouvelles thérapies contre le cancer, telles que les conjugués anticorps-médicaments (ADC) (4174. TWO), et TegMine Therapeutics, Inc. (TegMine), une entreprise biopharmaceutique américaine spécialisée dans le développement d’anticorps de premier ordre ciblant les glycanes et glycoprotéines tumoraux, ont conclu un accord-cadre de services (MSA) portant sur les ADC.

OBI Pharma geht AWK-Zusammenarbeit mit TegMine Therapeutics bei der Nutzung von GlycOBI® und TegMiner™ Enabling Technologies ein

TAIPEI, Taiwan, June 06, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), ein globales, im klinischen Stadium tätiges Onkologieunternehmen, das auf die Entwicklung neuartiger Krebstherapien wie Antikörper-Wirkstoff-Konjugate (AWK) (4174. TWO) spezialisiert ist, und TegMine Therapeutics, Inc. (TegMine), ein US-Biopharmaunternehmen, das erstklassige Antikörper entwickelt, die auf Krebsglykane und Glykoproteine abzielen, haben einen AWK-bezogenen Rahmendienstleistungsvertrag abgeschlossen.

The Memory Breath Introduces 3-Second Breathing Technique Inspired by Scientific Research on Mindful Focus

Dr. Brian Johnson Introduces Digital Breathing Program Aimed at Enhancing Mindful Focus

Dr. Brian Johnson Introduces Digital Breathing Program Aimed at Enhancing Mindful Focus

Steelworkers Humanity Fund donates $20,000 to support wildfire relief efforts in Saskatchewan

The Steelworkers Humanity Fund’s latest $20,000 donation will assist those affected by the wildfires in Saskatchewan with immediate and ongoing relief.

Le Fonds humanitaire des Métallos soutient les efforts d’aide aux victimes des feux de forêt en Saskatchewan par un don de 20 000 $

TORONTO, 06 juin 2025 (GLOBE NEWSWIRE) -- Dans le but de soutenir les personnes et les collectivités évacuées à cause des récents feux de forêt en Saskatchewan, le Fonds humanitaire des Métallos (FHM) fait un don additionnel de 20 000 $.

Silvano Fashion Group AS Consolidated Annual Report 2024

At its meeting held on 06 June 2025, the Supervisory Board of Silvano Fashion Group AS approved the annual report of Silvano Fashion Group AS for the financial year 2024 and for submission to the general meeting of shareholders.

Bragar Eagel & Squire, P.C. is Investigating CaaStle, Inc. on Behalf of Stockholders and Encourages Fund Investors to Contact the Firm

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of investors of fashion startup CaaStle, Inc. Our investigation concerns whether CaaStle has violated the federal securities laws and/or engaged in other unlawful business practices.

AS Silvano Fashion Group 2024. aasta konsolideeritud majandusaasta aruanne

Silvano Fashion Group AS-i nõukogu kiitis 06.06.2025 toimunud koosolekul heaks Silvano Fashion Group AS-i 2024. aasta majandusaasta aruande ja tegi ettepaneku esitamiseks aktsionäride üldkoosolekule.

Dr. Louis Krenn Medical Scholarship Invites Aspiring Physicians to Shape the Future of Healthcare

SPRINGFIELD, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- The Dr. Louis Krenn Medical Scholarship announces a new opportunity for undergraduate and medical students across the United States to advance their journey toward a career in medicine. This prestigious one-time award, established by Dr. Louis Krenn, a distinguished Family Medicine physician, aims to support the next generation of healthcare professionals who demonstrate a commitment to service, innovation, and compassion. The scholarship, open to students nationwide, invites applicants to share their vision for the future of medicine through a thought-provoking essay.

- A word from our sponsors -

HomeAuthorsPosts by globenewswire